decisionhealth Newsletters, Part B News - 2010 Issue 5 (May)
CMS clarifies billing discarded drug amounts with modifier JW
Subscribe or sign in to view the full article.
Article Overview
This article covers recent CMS clarification on how discarded drug and biological amounts are handled in Medicare billing, including an update to the Claims Processing Manual and related transmittal guidance. It is relevant for coding and billing professionals who work with Part B drug claims and need to understand the general reporting framework for discarded amounts, reimbursement handling, and exceptions referenced by CMS.
Why This Topic Matters
The article highlights CMS billing guidance that affects how discarded drug amounts are reported and paid on Medicare claims, making it important for providers and billing staff who process drug administration services.
Article Sections
-
CMS guidance on discarded drug amounts
An overview of CMS clarification on reporting discarded or unused drug and biological amounts and the related claims processing update.
-
Examples and exceptions
General illustrative scenarios and the situations CMS identifies where the discarded-amount reporting approach does not apply.
-
Competitive Acquisition Program note
A brief discussion of how the guidance relates to the Competitive Acquisition Program for Part B drugs and the program timing context.
What You Will Learn
- How CMS frames reporting of discarded drug and biological amounts
- What types of discarded-amount situations are addressed in the guidance
- Which broader Medicare billing topics and exceptions are discussed
- How the CMS update relates to claims processing documentation
Who Should Read This
- Medical coders
- Billing staff
- Practice managers
- Revenue cycle professionals
- Pharmacy billing staff
- Compliance teams
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com